financetom
Business
financetom
/
Business
/
Factbox-Who is Burberry's new CEO and luxury veteran Joshua Schulman?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Factbox-Who is Burberry's new CEO and luxury veteran Joshua Schulman?
Jul 15, 2024 2:00 AM

(Reuters) - British luxury brand Burberry named Joshua Schulman as its new CEO on Monday after warning on profit and scrapping its dividend payment for this year.

He will become Burberry's ( BBRYF ) fourth CEO in 10 years, replacing Jonathan Akeroyd who was axed after two years in the role.

Schulman starts his new job on Wednesday, with a base annual salary of 1.2 million pounds ($1.56 million).

Here's what you need to know about Schulman.

WHO IS HE?

Schulman, 52, is a Los Angeles native who attended New York University and Parsons School of Design. He has worked in the fashion industry for more than 33 years, including at least 24 in executive positions, according to his LinkedIn profile.

He will move to London from New York City for the new role.

CAREER

From 2021 to 2022, Schulman was CEO of Michael Kors and was lined up to take over the CEO role at parent firm Capri Holdings ( CPRI ) but left just months before that.

He was CEO at Coach and served as brand president from 2017 to 2020. He was credited with turning around the Tapestry Inc ( TPR )-owned Coach brand.

From 2007 to 2012, Schulman was CEO of Jimmy Choo in London.

Before that, he was at Neiman Marcus Group as president of luxury department store Bergdorf Goodman for five years.

Earlier, he was at Yves Saint Laurent and held roles at Gucci.

WHAT'S THE PLAN?

Schulman will be tasked with Burberry ( BBRYF ) turnaround from a year-long, industry-wide struggle with weak demand for luxury goods, especially in China.

Besides a cost-cutting plan, he will also oversee a product "rebalancing" initiative to include everyday luxury products in Burberry's ( BBRYF ) portfolio and will lead a refocused marketing plan.

"Its (Burberry's ( BBRYF )) original purpose to protect people from the weather is more relevant than ever," Schulman said in a statement. ($1 = 0.7705 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Life360 Plans $250 Million Notes Offering
Life360 Plans $250 Million Notes Offering
Jun 2, 2025
06:13 AM EDT, 06/02/2025 (MT Newswires) -- Life360 ( LIF ) said Monday it is planning to offer $250 million convertible senior notes due 2030 in a private placement to eligible purchasers. The company expects to grant the initial purchasers a 13-day option to purchase up to $37.5 million in additional amount of notes. Net proceeds will be used to...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Topgolf Callaway Brands Closes Jack Wolfskin Sale for $290 Million
Topgolf Callaway Brands Closes Jack Wolfskin Sale for $290 Million
Jun 2, 2025
06:11 AM EDT, 06/02/2025 (MT Newswires) -- Topgolf Callaway Brands ( MODG ) said Monday it completed the sale of its Jack Wolfskin unit to ANTA Sports for $290 million. The deal closed effective Saturday, the company said. ...
Novartis Reports New Data From Phase 2 Trial of Kisqali in Breast Cancer
Novartis Reports New Data From Phase 2 Trial of Kisqali in Breast Cancer
Jun 2, 2025
06:10 AM EDT, 06/02/2025 (MT Newswires) -- Novartis ( NVS ) said Sunday that data from a new subgroup analysis of a phase 2 trial evaluating Kisqali, plus endocrine therapy, in patients with stage II and III hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer showed reduced risk of recurrence across all efficacy measures. The company said data...
Copyright 2023-2026 - www.financetom.com All Rights Reserved